Jean-philippe Azulay
Jean-philippe Azulay
Unknown affiliation
Verified email at ap-hm.fr
Title
Cited by
Cited by
Year
Nonmotor fluctuations in Parkinsonís disease Frequent and disabling
T Witjas, E Kaphan, JP Azulay, O Blin, M Ceccaldi, J Pouget, M Poncet, ...
Neurology 59 (3), 408-413, 2002
7122002
Visual control of locomotion in Parkinson's disease
JP Azulay, S Mesure, B Amblard, O Blin, I Sangla, J Pouget
Brain 122 (1), 111-120, 1999
4111999
Postural deformities in Parkinson's disease
KM Doherty, BP van de Warrenburg, MC Peralta, L Silveira-Moriyama, ...
The Lancet Neurology 10 (6), 538-549, 2011
3902011
Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti‐GM1 antibodies: a double‐blind, placebo‐controlled study
JP Azulay, O Blin, J Pouget, J Boucraut, F Bille-Turc, G Carles, ...
Neurology 44 (3 Part 1), 429-429, 1994
3021994
Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation
T Witjas, C Baunez, JM Henry, M Delfini, J Regis, AA Cherif, JC Peragut, ...
Movement disorders: official journal of the Movement Disorder Society 20 (8†Ö, 2005
2452005
Impaired vertical postural control and proprioceptive integration deficits in Parkinsonís disease
M Vaugoyeau, S Viel, C Assaiante, B Amblard, JP Azulay
Neuroscience 146 (2), 852-863, 2007
1882007
MUSK, a new target for mutations causing congenital myasthenic syndrome
F Chevessier, B Faraut, A Ravel-Chapuis, P Richard, K Gaudon, ...
NEUROMUSCULAR DISORDERS 15 (9-10), 736-736, 2005
1822005
MUSK, a new target for mutations causing congenital myasthenic syndrome
F Chevessier, B Faraut, A Ravel-Chapuis, P Richard, K Gaudon, ...
Human molecular genetics 13 (24), 3229-3240, 2004
1822004
Postural disorders in Parkinsonís disease
I Benatru, M Vaugoyeau, JP Azulay
Neurophysiologie Clinique/Clinical Neurophysiology 38 (6), 459-465, 2008
1782008
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ...
The Lancet Neurology 16 (9), 701-711, 2017
1762017
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo†Ö
C Moreau, A Delval, L Defebvre, K Dujardin, A Duhamel, G Petyt, ...
The Lancet Neurology 11 (7), 589-596, 2012
1682012
Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease
T Witjas, E Kaphan, J Régis, E Jouve, AA Chérif, JC Péragut, JP Azulay
Movement disorders: official journal of the Movement Disorder Society 22 (12†Ö, 2007
1642007
Influence of visual cues on gait in Parkinson's disease: contribution to attention or sensory dependence?
JP Azulay, S Mesure, O Blin
Journal of the neurological sciences 248 (1-2), 192-195, 2006
1632006
Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy
O Blin, C Desnuelle, O Rascol, M Borg, HP Saint Paul, JP Azulay, F Bille, ...
Journal of the neurological sciences 125 (1), 95-101, 1994
1591994
Dopaminergic modulation of the default mode network in Parkinson's disease
P Delaveau, P Salgado-Pineda, P Fossati, T Witjas, JP Azulay, O Blin
European Neuropsychopharmacology 20 (11), 784-792, 2010
1252010
Apomorphine‐induced blinking and yawning in healthy volunteers.
O Blin, G Masson, JP Azulay, J Fondarai, G Serratrice
British journal of clinical pharmacology 30 (5), 769-773, 1990
1241990
Withdrawing amantadine in dyskinetic patients with Parkinson disease The AMANDYSK trial
F Ory-Magne, JC Corvol, JP Azulay, AM Bonnet, C Brefel-Courbon, ...
Neurology 82 (4), 300-307, 2014
1232014
Multifocal motor neuropathy with and without conduction block A single entity?
E Delmont, JP Azulay, R Giorgi, S Attarian, A Verschueren, D Uzenot, ...
Neurology 67 (4), 592-596, 2006
1222006
CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5
C Goizet, A Boukhris, A Durr, C Beetz, J Truchetto, C Tesson, ...
Brain 132 (6), 1589-1600, 2009
1212009
Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial
D Devos, C Moreau, D Maltête, R Lefaucheur, A Kreisler, A Eusebio, ...
J Neurol Neurosurg Psychiatry 85 (6), 668-674, 2014
1192014
The system can't perform the operation now. Try again later.
Articles 1–20